BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2860164)

  • 1. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
    Schuhman G; Vidic B
    J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial preparation of the eye for surgery.
    Apt L; Isenberg SJ; Yoshimori R
    J Hosp Infect; 1985 Mar; 6 Suppl A():163-72. PubMed ID: 2860163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
    Özen Tunay Z; Ozdemir O; Petricli IS
    Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
    Bekmez S; Eris E
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
    Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
    Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
    Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyvinylpyrrolidone iodine collyrium].
    Coppens A; Peene J
    Bull Soc Belge Ophtalmol; 1983; 206():85-90. PubMed ID: 6671142
    [No Abstract]   [Full Text] [Related]  

  • 8. The palliative treatment of the dry eye.
    Völker-Dieben HJ; Kok-van Alphen CC; Hollander J; Kruit PJ; Batenburg K
    Doc Ophthalmol; 1987; 67(1-2):221-7. PubMed ID: 2448103
    [No Abstract]   [Full Text] [Related]  

  • 9. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
    Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
    Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
    Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO
    Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Povidone-iodine eyedrops for the prevention of newborn conjunctivitis].
    Buchmann P
    Dtsch Med Wochenschr; 1995 Nov; 120(47):1645. PubMed ID: 7493570
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis.
    Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P
    J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery.
    Isenberg SJ; Apt L; Yoshimori R; Pham C; Lam NK
    Am J Ophthalmol; 1997 Jul; 124(1):31-5. PubMed ID: 9222229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac.
    Halachmi-Eyal O; Lang Y; Keness Y; Miron D
    J Cataract Refract Surg; 2009 Dec; 35(12):2109-14. PubMed ID: 19969216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections.
    Safar A; Dellimore MC
    Int Ophthalmol; 2007 Oct; 27(5):307-12. PubMed ID: 17440685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico.
    Ramirez-Ortiz MA; Rodriguez-Almaraz M; Ochoa-Diazlopez H; Diaz-Prieto P; Rodriguez-Suárez RS
    Br J Ophthalmol; 2007 Nov; 91(11):1430-4. PubMed ID: 17947266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical 1.25% povidone-iodine eyedrops used for prophylaxis of ophthalmia neonatorum on renal iodine excretion and thyroid-stimulating hormone level.
    Richter R; Below H; Kadow I; Kramer A; Müller C; Fusch C
    J Pediatr; 2006 Mar; 148(3):401-3. PubMed ID: 16615978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis.
    Aydamirov AS; Harbiyeli II; Ozturk G; Yarkin F; Erdem E; Yagmur M
    Int Ophthalmol; 2023 May; 43(5):1701-1710. PubMed ID: 36346478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of povidone iodine and hydroxyethyl cellulose, alone and in combination, against common feline ocular pathogens.
    Pennington MR; Capriotti JA; Van de Walle GR
    Vet J; 2018 Nov; 241():38-41. PubMed ID: 30340658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study.
    Trinavarat A; Atchaneeyasakul LO
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):53-8. PubMed ID: 21916618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.